JENBURKT PHARMACEUTICALS LTD.
BSE: 524731
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|---|---|---|
| INCOME | |||||||
| Revenue | 44.63+3.7% | 43.02-5.6% | 45.56+28.2% | 35.53-13.4% | 41.05+11.3% | 36.89-10.5% | 41.22 |
| Other Income | 4.35+139.6% | 1.81-12.7% | 2.08+1.1% | 2.06+9.4% | 1.88+18.8% | 1.58-14.6% | 1.85 |
| Total Income | 48.98+9.2% | 44.84-5.9% | 47.64+26.7% | 37.58-12.4% | 42.93+11.6% | 38.48-10.7% | 43.07 |
| EXPENSES | |||||||
| Expenditure | 31.32-14.3% | 36.54+9.7% | 33.30+21.5% | 27.40-11.9% | 31.09+7.4% | 28.96-5.2% | 30.55 |
| Tax | 2.86+20.9% | 2.37-43.3% | 4.17+74.4% | 2.39-27.5% | 3.30+9.7% | 3.01+2.9% | 2.92 |
| PROFIT | |||||||
| PBT | 13.71+65.2% | 8.30-42.1% | 14.33+40.8% | 10.18-14.0% | 11.84+24.4% | 9.51-24.0% | 12.52 |
| Net Profit | 10.85+82.9% | 5.93-41.6% | 10.16+30.4% | 7.79-8.7% | 8.54+31.2% | 6.51-32.2% | 9.60 |
| KEY METRICS | |||||||
| OPM % | 23.07%+5.80pp | 17.27%-11.49pp | 28.76%+3.55pp | 25.21%-1.24pp | 26.45%+7.36pp | 19.09%-4.97pp | 24.06% |
| NPM % | 22.15%+8.92pp | 13.23%-8.11pp | 21.34%+0.61pp | 20.73%+0.84pp | 19.89%+2.98pp | 16.91%-5.38pp | 22.29% |
| EPS | 24.58+82.9% | 13.44-41.6% | 23.03+30.4% | 17.66-8.7% | 19.34+31.1% | 14.75-32.2% | 21.75 |
Corporate Events
Board MeetingJENBURPH*
202528Jan
Board Meeting
Approval of standalone unaudited financial results for the q…
BSE Filing ↗ Board MeetingJENBURPH*
20245Nov
Board Meeting
Consider and approve Standalone unaudited financial results …
BSE Filing ↗ Board MeetingJENBURPH*
20246Feb
Board Meeting
consider and approve the Standalone unaudited financial resu…
BSE Filing ↗ Board MeetingJENBURPH*
20237Nov
Board Meeting
consider and approve unaudited financial results for the qua…
BSE Filing ↗